Harnessing Pentameric Scaffold of Cholera Toxin B (CTB) for Design of Subvirion Recombinant Dengue Virus Vaccine
Vaccines · 17.01.2024 · 12 (1) · 92
DOI: 10.3390/vaccines12010092 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vaccines, online erschienen am 17.01.2024. Verfasst von Jemin Sung und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul 03722, Republic of Korea. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: VITAL-Korea project from the Ministry of Health and Welfare (MoHW) of the Korean Government, National Research Foundation (NRF).
Abstract (Originalsprache)
Dengue virus is an enveloped virus with an icosahedral assembly of envelope proteins (E). The E proteins are arranged as a head-to-tail homodimer, and domain III (EDIII) is placed at the edge of the dimer, converging to a pentamer interface. For a structure-based approach, cholera toxin B (CTB) was harnessed as a structural scaffold for the five-fold symmetry of EDIII. Pivoted by an RNA-mediated chaperone for the protein folding and assembly, CTB-EDIII of dengue serotype 1 (DV1) was successfully produced as soluble pentamers in an E. coli host with a high yield of about 28 mg/L. Immunization of mice with CTB-DV1EDIII elicited increased levels of neutralizing antibodies against infectious viruses compared to the control group immunized with DV1EDIII without CTB fusion. IgG isotype switching into a balanced Th1/Th2 response was also observed, probably triggered by the intrinsic adjuvant activity of CTB. Confirming the immune-enhancing potential of CTB in stabilizing the pentamer assembly of EDIII, this study introduces a low-cost bacterial production platform designed to augment the soluble production of subunit vaccine candidates, particularly those targeting flaviviruses.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul 03722, Republic of Korea.
- The Interdisciplinary Graduate Program in Integrative Biotechnology & Translational Medicine, Yonsei University, Incheon 21983, Republic of Korea.
- Department of Pediatrics, College of Medicine, Yonsei University, Seoul 03722, Republic of Korea.
- POSTECH Biotech Center, Pohang University of Science and Technology (POSTECH), Pohang 37673, Republic of Korea.
- Department of Microbiology and Immunology, College of Medicine, Yonsei University, Seoul 03722, Republic of Korea.
- Vaccine Innovative Technology ALliance (VITAL)-Korea, Yonsei University, Seoul 03722, Republic of Korea.
ORCID-Profile: Sanguine Byun, Baik-Lin Seong
Förderung
- VITAL-Korea project from the Ministry of Health and Welfare (MoHW) of the Korean Government
- National Research Foundation (NRF)
Zitieren
APA
Sung, J., Cheong, Y., Kim, Y. S., Ahn, J., Sohn, M. H., Byun, S., & Seong, B. L. (2024). Harnessing Pentameric Scaffold of Cholera Toxin B (CTB) for Design of Subvirion Recombinant Dengue Virus Vaccine. Vaccines, 12(1), 92. https://doi.org/10.3390/vaccines12010092
Vancouver
Sung J, Cheong Y, Kim YS, Ahn J, Sohn MH, Byun S, et al. Harnessing Pentameric Scaffold of Cholera Toxin B (CTB) for Design of Subvirion Recombinant Dengue Virus Vaccine. Vaccines. 2024;12(1):92. doi:10.3390/vaccines12010092
BibTeX
@article{Sung2024,
author = {Sung, Jemin and Cheong, Yucheol and Kim, Young-Seok and Ahn, Jina and Sohn, Myung Hyun and Byun, Sanguine and Seong, Baik-Lin},
title = {Harnessing Pentameric Scaffold of Cholera Toxin B (CTB) for Design of Subvirion Recombinant Dengue Virus Vaccine},
journal = {Vaccines},
year = {2024},
volume = {12},
number = {1},
pages = {92},
doi = {10.3390/vaccines12010092}
}
EUVIMED